D-Optimal Design and Development of a Koumine-Loaded Microemulsion for Rheumatoid Arthritis Treatment: In vivo and in vitro Evaluation
DOI: https://doi.org/10.2147/IJN.S406641
IF: 7.033
2023-06-05
International Journal of Nanomedicine
Abstract:Qing Hu, 1, 2, &ast Xiao-Ling Fu, 1, &ast Yi-Yan Dong, 1, 2 Ju Ma, 1 Jian Hua, 1 Jia-Ting Li, 1 Kai-Xin Liu, 1 Jian Yang, 1, 2 Chang-Xi Yu 1, 2 1 School of Pharmacy, Fujian Medical University, Fuzhou, People's Republic of China; 2 Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, School of Pharmacy, Fujian Medical University, Fuzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chang-Xi Yu; Jian Yang, School of Pharmacy, Fujian Medical University, No. 1 Xuefu North Road, Fuzhou, 350122, People's Republic of China, Tel +86-0591-22862016, Email ; Introduction: Koumine (KME) is the most abundant active ingredient separated from Gelsemium elegans Benth and exhibits a significant therapeutic effect on rheumatoid arthritis (RA). It is a lipophilic compound with poor aqueous solubility, and there is an urgent need to develop novel dosage forms of KME and promote its clinical application for the treatment of RA. The aim of this study was to design and develop KME-loaded microemulsions (KME-MEs) for the effective management of RA. Methods: The composition of the microemulsion was selected by carrying out a solubility study and generating pseudoternary phase diagrams, and further optimized by D-Optimal design. The optimized KME-MEs was evaluated for particle size, viscosity, drug release, storage stability, cytotoxicity, cellular uptake, Caco-2 cell transport and everted gut sac investigations. In vivo fluorescence imaging and the therapeutic effects of KME and KME-MEs on collagen-induced arthritis (CIA) rats were also evaluated. Results: The optimized microemulsion contained 8% oil, 32% S mix (surfactant/cosurfactant) and 60% water and was used for in vivo and in vitro studies. The optimal KME-MEs exhibited a small globule size of 18.5 ± 0.14 nm and good stability over 3 months, and the release kinetics followed a first-order model. These KME-MEs had no toxic effect on Caco-2 cells but were efficiently internalized into the cytoplasm. Compared to KME, the KME-MEs displayed significantly increased permeability and absorption in Caco-2 cell monolayer assay and ex vivo everted gut sac experiment. As expected, the KME-MEs attenuated the progression of RA in CIA rats and were more effective than free KME with a reduced frequency of administration. Conclusion: The KME-MEs improved the solubility and therapeutic efficacy of KME by employing formulation technology. These results provide a promising vehicle for the oral delivery of KME to treat RA and have attractive potential for clinical translation. Graphical Keywords: rheumatoid arthritis, koumine, microemulsion, permeability, oral administration Graphical Rheumatoid arthritis (RA) is one of the most common chronic, complex, and heterogeneous autoimmune diseases that is characterized by symmetric polyarthritis and synovial hypertrophy and often results in joint damage, bone and cartilage destruction, and even deformities. 1 In Chinese populations, the prevalence of RA is 0.28%~0.41%, and the total number of patients is nearly 5 million. It has been reported that 80% of RA patients have incomplete disability, which seriously affects their quality of life and life expectancy. In general, RA patients are thought to have a shorter life expectancy of 10 to 15 years. 2 The pathogenesis of RA is not fully understood, and current RA medications include non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), biologics, JAK inhibitors and steroidal medications. 3 RA treatments have been continuously developed, with the discovery of new target strategies, new pathways, and new cells and molecules. 4,5 However, even after such encouraging developments, the treatment of RA remains one of the most critical challenges due to the possibility of adverse reactions, and some patients may not respond to treatment. The development of novel RA drugs is therefore imperative, and scientists are exploring new strategies to achieve this aim through various innovative approaches. Gelsemium elegans Benth ( G. elegans ) is a highly poisonous plant that belongs to the family Loganiaceae and genus Gelsemium. It is native to Southeast Asia and is found in Southeast China, India and Indonesia. 6 Until now, a total of 121 alkaloids have been found in G. elegans , among which koumine (KME) is the most abundant alkaloid, and has various biological effects including anti-inflam -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology